drugset / Trial / NCT00602420

Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)

NCT00602420

RandomizedParallel-groupTriple-blindSupportive care

Summary

RATIONALE: Naproxen may help prevent or lessen bone pain caused by pegfilgrastim. It is not yet known whether naproxen is more effective than a placebo in preventing bone pain caused by pegfilgrastim in patients with non-hematologic cancer undergoing chemotherapy. PURPOSE: This randomized phase III trial is studying naproxen to see how well it works compared with a placebo in preventing bone pain caused by pegfilgrastim in patients with non-hematologic cancer undergoing chemotherapy.

Timeline

Start
2008-06
Primary completion
2012-01
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Naproxen Small molecule Oral